Capstone Therapeutics
Get Full AccessDescription
- Capstone Therapeutics (OTCQB: CAPS) is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. Capstone holds an FDA Orphan drug designation for its lead molecule, AEM-28, for Homozygous Familial Hypercholesterolemia (HoFH) and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.
-
Headquarters:1275 West Washington Street , Tempe, Arizona, United States
More -
Phone Number: +1 800-937-5520
-
Website: https://www.capstonethx.com
-
Employees:9
-
Revenue:$10 - 50M
-
Legal Name:Capstone Therapeutics
-
Capstone Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Capstone Therapeutics
-
Where are Capstone Therapeutics's Headquarters?
Capstone Therapeutics's Headquarters are in 1275 West Washington Street ,Tempe,Arizona,United States
-
What is Capstone Therapeutics's phone number?
Capstone Therapeutics's phone number is +1 800-937-5520
-
What is Capstone Therapeutics's official website?
Capstone Therapeutics's official website is https://www.capstonethx.com
-
What is Capstone Therapeutics's Revenue?
Capstone Therapeutics's revenue is $10 - 50M
-
What is Capstone Therapeutics's NAICS code?
Capstone Therapeutics's NAICS code is 325412
-
How many employees are working in Capstone Therapeutics
Capstone Therapeutics has 9 employees
-
What is Capstone Therapeutics's Industry?
Capstone Therapeutics is in the industry of Biotechnology
-
Who is Capstone Therapeutics's Chief Financial Officer?
Capstone Therapeutics's Chief Financial Officer is Les Taeger

